# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Angioedema, hereditary, type II

C1 esterase inhibitor deficiencyC1 inhibitor deficiencyHANEHereditary angioneurotic edema
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-4 of 4 results.
Biomarker for Hereditary AngioEdema Disease
Status: Recruiting
Last Changed: Aug 19, 2020
First Received: Jan 24, 2017
Disease(s): C1 Esterase Inhibitor Deficiency, Angio Edema, C4 Deficiency, HAE, Hereditary Angioedema, Hereditary Angioedema Type II, Hereditary Angioedema Type III, Hereditary Angioedema Type I
Locations: Arabkir JMC-ICAH, Yerevan, Armenia
Center of Allergy and Immunology, Tbilisi, Georgia
Centrul Clinic Mediquest, Târgu-Mureş, Romania
Hereditary Angioedema Kininogen Assay
Status: Recruiting
Last Changed: Jul 01, 2020
First Received: Sep 16, 2019
Disease(s): Hereditary Angioedema
Locations: Charité - Universitätsmedizin Berlin, Berlin, Germany
Klinikum der Johann-Wolfgang-Goethe-Universität, Frankfurt, Germany
Medizinische Hochschule Hannover, Hannover, Germany
Universitäts-Hautklinik Leipzig, Leipzig, Germany
Hämophilie-Zentrum Rhein Main GmbH, Mörfelden-Walldorf, Germany
... and 2 other locations.
Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II
Status: Recruiting
Last Changed: Feb 05, 2019
First Received: Feb 04, 2019
Disease(s): Hereditary Angioedema Type I and II
Intervention(s): functional and antigenic C1 inhibitor
Locations: ASST FBF Sacco, Milan, Italy
A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II
Status: Recruiting
Last Changed: Aug 28, 2020
First Received: Dec 23, 2019
Disease(s): Hereditary Angioedema
Intervention(s): KVD900, Placebo
Locations: KalVista Investigative Site, Scottsdale, Arizona, United States
KalVista Investigative Site, Centennial, Colorado, United States
KalVista Investigative Site, Chevy Chase, Maryland, United States
KalVista Investigative Site, Cincinnati, Ohio, United States
KalVista Investigative Site, Dallas, Texas, United States
... and 21 other locations.